Literature DB >> 189804

Different metal-binding properties of the two sites of human transferrin.

D C Harris.   

Abstract

Transferrin, the serum serum iron-transport protein which can bind two metal ions at physiologic pH, binds just one Fe3+, VO2+, or Cr3+ ion at pH 6.0. Fe3+ and VO2+ appear to be bound at the same site, designated A, based on electron paramagnetic resonance (EPR) spectra of VO2+-transferrin and (Fe3+)1(VO2+)1-transferrin. The EPR spectra of (Cr3+)1(VO2+)1-transferrin and of (Cr3+), (FE3+)1-transferrin indicate that that Cr3+ is bound to site B at pH 6.0. Transferrin was labeled at site A with 59Fe at pH 6.0 and at site B with 55Fe at pH 7.5. When the pH of the resulting preparation was lowered to 6.3 and the dissociated iron was separated by gel filtration, about ten times as much 55Fe as 59Fe was lost. The same EPR and isotopic-labeling experiments showed that Fe3+ added to transferrin at pH 7.5 binds to site A with about 90% selectivity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189804     DOI: 10.1021/bi00622a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Studies of the binding of different iron donors to human serum transferrin and isolation of iron-binding fragments from the N- and C-terminal regions of the protein.

Authors:  R W Evans; J Williams
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

2.  Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses.

Authors:  Gang Cheng; Jing Pan; Radoslaw Podsiadly; Jacek Zielonka; Alexander M Garces; Luiz Gabriel Dias Duarte Machado; Brian Bennett; Donna McAllister; Michael B Dwinell; Ming You; Balaraman Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

3.  High-yield production of functionally active human serum transferrin using a baculovirus expression system, and its structural characterization.

Authors:  S A Ali; H C Joao; R Csonga; F Hammerschmid; A Steinkasserer
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  The influence of pH on the equilibrium distribution of iron between the metal-binding sites of human transferrin.

Authors:  N D Chasteen; J Williams
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

5.  The distribution of iron between the metal-binding sites of transferrin human serum.

Authors:  J Williams; K Moreton
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

6.  The time-dependent transport of chromium in adult rats from the bloodstream to the urine.

Authors:  Buffie J Clodfelder; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2005-04-27       Impact factor: 3.358

7.  Speciation of chromium in plasma and liver tissue of endstage renal failure patients on continuous ambulatory peritoneal dialysis.

Authors:  F Borguet; R Cornelis; N Lameire
Journal:  Biol Trace Elem Res       Date:  1990 Jul-Dec       Impact factor: 3.738

8.  Effects of metal compounds with distinct physicochemical properties on iron homeostasis and antibacterial activity in the lungs: chromium and vanadium.

Authors:  Mitchell D Cohen; Maureen Sisco; Colette Prophete; Kotaro Yoshida; Lung-chi Chen; Judith T Zelikoff; Jason Smee; Alvin A Holder; Jacqueline Stonehuerner; Debbie C Crans; Andrew J Ghio
Journal:  Inhal Toxicol       Date:  2010-02       Impact factor: 2.724

9.  Low-Temperature EPR Spectroscopy as a Probe-Free Technique for Monitoring Oxidants Formed in Tumor Cells and Tissues: Implications in Drug Resistance and OXPHOS-Targeted Therapies.

Authors:  Balaraman Kalyanaraman; Gang Cheng; Jacek Zielonka; Brian Bennett
Journal:  Cell Biochem Biophys       Date:  2018-09-26       Impact factor: 2.194

10.  Significance of conformation changes during the binding and release of chromium(III) from human serum transferrin.

Authors:  Kyle C Edwards; Hannah Kim; Riley Ferguson; Molly M Lockart; John B Vincent
Journal:  J Inorg Biochem       Date:  2020-02-15       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.